VINC – vincerx pharma, inc. (US:NASDAQ)
Stock Stats
News
Vincerx Pharma Reports Third Quarter 2024 Financial Results
Vincerx Pharma, Inc. (NASDAQ: VINC) had its price target lowered by analysts at Leerink Partners from $4.00 to $2.00. They now have an "outperform" rating on the stock.
Vincerx Reports Positive Initial Clinical Data from Ongoing VIP943 Phase 1 Dose-Escalation Study and Provides Pipeline and Corporate Updates
Form SC 13G Vincerx Pharma, Inc. Filed by: ARMISTICE CAPITAL, LLC
Form SC 13G/A Vincerx Pharma, Inc. Filed by: BANK OF AMERICA CORP /DE/
Form SC 13G/A Vincerx Pharma, Inc. Filed by: Prosight Management, LP
Form 8-K Vincerx Pharma, Inc. For: Nov 12
Form 10-Q Vincerx Pharma, Inc. For: Sep 30
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.